Sequent Scien.

SEQUENTSCIENTIFIC30 Apr 2024

Pharmaceuticals

₹

-2.70 (-2.14%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Sequent Scien.

Sequent Scien.

Pharmaceuticals

SEQUENTSCIENTIFIC30 Apr 2024

₹

-2.70 (-2.14%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
29-Oct-2015	S	Sequent Scientific Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 29, 2015, has approved the sub-division (stock split) of one equity share of the Company having a face value of Rs. 10/- each into five equity shares of face value of Rs. 2/- each. The sub-division of shares will be subject to approval by the shareholders of the Company and any other statutory and regulatory approvals. SUB. :- Sub Division of equity shares of Sequent Scientific Limited (Scrip Code 512529) Trading Members of the Exchange are hereby informed that, Sequent Scientific Ltd. has fixed the Record Date for the purpose of sub division of equity shares of the company. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Sequent Scientific Ltd. (512529) RECORD DATE 26/02/2016 PURPOSE Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into FIVE equity shares of Rs.2/- each. SUB-DIVIDED PAID-UP VALUE Rs.2/- SUB-DIVIDED PAID-UP VALUE W.E.F. 25/02/2016 DR-227/2015- 2016 Note:- i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs. 2/- paid up w.e.f. 25/02/2016. ii. ISIN No. INE807F01019 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 25/02/2016. iii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 12.02.2016)	26-Feb-2016
30-Jun-2021	D	The Board of Directors at their meeting held today have recommended a final dividend of Rs. 0.50 (25%) per equity share for the financial year ended March 31, 2021.	08-Sep-2021
14-May-2019	D	Sequent Scientific Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 14, 2019, inter alia, has recommended dividend at the rate of 10% i.e. INR 0.20 paise per share for the financial year ended March 31, 2019.	21-Aug-2019
09-Nov-2017	D	The Board had at its Meeting held today a) Approved an Interim Dividend of INR 20 paise per equity share having face value of INR 2 each for Financial Year 2017-18. b) Have fixed November 21, 2017 as the 'Record Date' for the purpose of payment of said interim dividend to shareholders. The aforesaid interim dividend will be paid /despatched before December 4, 2017 to the shareholders. You are requested to take the same on record. Sequent Scientific Ltd has informed BSE that the Board of Directors in their meeting held on November 09, 2017, inter alia, has declared an interim dividend of 10% i.e. Rs. 0.20 per equity share of Rs. 2/- each.	20-Nov-2017
27-May-2011	D	Sequent Scientific Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2011, inter alia, has recommended dividend at 15% viz., Rs. 1.50 per share for the year ended March 31, 2011.	16-Sep-2011
29-May-2010	D	Sequent Scientific Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2010, inter alia, has recommended a dividend of Rs. 2 (20%) per equity share of Rs. 10/- for the year.	23-Sep-2010
23-Jun-2009	D	PI Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 22, 2009, inter alia, has recommended a dividend of 10% to the Equity Shareholders for the financial year 2008-09.	02-Sep-2009
27-Jun-2008	D	PI Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 27, 2008, inter alia, has recommended a dividend of 10% to the Equity shareholders for the financial year 2007-08.	11-Sep-2008
21-Jun-2007	D	PI Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 20, 2007, inter alia, has recommend a Dividend of Rs 1/- per Equity Shares (10%) subject to approval of the Shareholders	13-Sep-2007
04-Apr-2024	BC	Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Intimation of resignation of Mr. Sharat Pandurang Narasapur Joint Managing Director.	30-Apr-2024
16-Apr-2024	BC	Appointment Of Director	17-Apr-2024
05-Feb-2024	BC	Pursuant to Regulation 30 (read with Part A of Schedule III) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR'), we would	07-Mar-2024
13-Feb-2024	BC	Appointment of Company Secretary and Compliance Officer	16-Feb-2024
06-Dec-2023	BC	We wish to inform you that Mr. Krunal Shah has resigned from the position of Company Secretary & Compliance Officer due to personal reasons. He will continue in his role till the close of business ho	15-Feb-2024

Announcement Date30-Jun-2021

Ex Dividend Date08-Sep-2021

Dividend(%)25

Announcement Date14-May-2019

Ex Dividend Date21-Aug-2019

Dividend(%)10

Announcement Date09-Nov-2017

Ex Dividend Date20-Nov-2017

Dividend(%)10

Announcement Date27-May-2011

Ex Dividend Date16-Sep-2011

Dividend(%)15

Announcement Date29-May-2010

Ex Dividend Date23-Sep-2010

Dividend(%)20

Announcement Date23-Jun-2009

Ex Dividend Date02-Sep-2009

Dividend(%)10

Announcement Date27-Jun-2008

Ex Dividend Date11-Sep-2008

Dividend(%)10

Announcement Date21-Jun-2007

Ex Dividend Date13-Sep-2007

Dividend(%)10

No Rights has been declared by SEQUENTSCIENTIFIC

Book Closure

Record Date	Split Date	Purpose
30-Apr-2024	-	Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Intimation of resignation of Mr. Sharat Pandurang Narasapur Joint Managing Director.
17-Apr-2024	-	Appointment Of Director
07-Mar-2024	01 Jan'1900	Pursuant to Regulation 30 (read with Part A of Schedule III) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR'), we would
16-Feb-2024	-	Appointment of Company Secretary and Compliance Officer
15-Feb-2024	-	We wish to inform you that Mr. Krunal Shah has resigned from the position of Company Secretary & Compliance Officer due to personal reasons. He will continue in his role till the close of business ho

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Sequent Scientific Ltd ₹123.65(-2.70/-2.14%)	123.65	-2.70	3,084.25	62.80	0.00	2.90
Lupin Ltd ₹1,645.90(+8.45/0.52%)	1,645.90	+8.45	75,011.91	132.21	36.39	3.89
Ipca Laboratories Ltd ₹1,339.50(+5.50/0.41%)	1,339.50	+5.50	33,983.68	89.10	61.69	5.47
J B Chemicals & Pharmaceuticals Ltd ₹1,905.25(-1.40/-0.07%)	1,905.25	-1.40	29,568.49	83.20	58.37	11.01
Sanofi India Ltd ₹8,325.55(+48.05/0.58%)	8,325.55	+48.05	19,173.74	53.41	32.46	18.88
IOL Chemicals & Pharmaceuticals Ltd ₹393.70(-2.80/-0.71%)	393.70	-2.80	2,311.24	-3.87	13.46	1.46

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	42.21	49.12	40.42	46.60	57.00	54.23
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	42.21	49.12	40.42	46.60	57.00	54.23
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	13.44	9.87	9.70	8.01	7.62	6.73
Total Income	55.65	58.99	50.12	54.61	64.62	60.96
Total Expenditure	46.36	56.82	55.74	52.64	65.75	63.81
PBIDT	9.29	2.17	-5.63	1.97	-1.12	-2.85
Interest	1.15	1.21	0.98	0.87	0.72	0.58
PBDT	8.14	0.96	-6.61	1.10	-1.84	-3.43
Depreciation	2.05	2.35	2.43	2.33	2.15	2.25
Tax	0.46	1.50	-1.50	0.78	-1.37	-0.19
Deferred Tax	1.05	-1.98	-0.73	-0.36	-1.40	-1.44
Reported Profit After Tax	4.58	-0.92	-6.80	-1.65	-1.23	-4.05
Extra-ordinary Items	0.00	0.00	-6.25	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	4.58	-0.92	-0.55	-1.65	-1.23	-4.05

EPS (Unit Curr.)	0.18	-0.04	-0.27	-0.07	-0.05	-0.16
EPS (Adj) (Unit Curr.)	0.18	-0.04	-0.27	-0.07	-0.05	-0.16
Calculated EPS (Unit Curr.)	0.18	-0.04	-0.27	-0.07	-0.05	-0.16
Calculated EPS (Adj) (Unit Curr.)	0.18	-0.04	-0.27	-0.07	-0.05	-0.16
Calculated EPS (Ann.) (Unit Curr.)	0.73	-0.15	-1.09	-0.26	-0.20	-0.65
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.73	-0.15	-1.09	-0.26	-0.20	-0.65
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	49.89	49.89	49.89	49.89	49.89	49.89
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00	2.00	2.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	22.01	4.42	-13.93	4.23	-1.96	-5.26
PBDTM(%)	19.28	1.95	-16.35	2.36	-3.23	-6.32
PATM(%)	10.85	-1.87	-16.82	-3.54	-2.16	-7.47

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	329.36	345.97	333.21	366.67	375.31	337.61
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	329.36	345.97	333.21	366.67	375.31	337.61
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	7.28	9.72	0.79	1.74	2.86	0.91
Total Income	336.64	355.68	334.00	368.41	378.18	338.52
Total Expenditure	307.11	330.84	364.96	431.63	364.98	334.74
PBIDT	29.53	24.85	-30.95	-63.23	13.20	3.78
Interest	12.58	12.58	10.48	10.87	9.73	8.12
PBDT	16.95	12.27	-41.44	-74.10	3.48	-4.34
Depreciation	15.46	15.36	14.24	14.71	13.67	13.38
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	4.54	17.67	-11.70	4.91	-0.40	3.83
Deferred Tax	-13.73	-13.88	-9.30	-1.27	-0.02	-17.11
Reported Profit After Tax	10.68	-6.88	-34.68	-92.44	-9.78	-4.44
Minority Interest After NP	2.41	1.50	0.17	1.14	-0.91	-0.69
Net Profit after Minority Interest	8.27	-8.38	-34.85	-93.57	-8.87	-3.75

Extra-ordinary Items	-1.78	-9.60	-23.51	-58.19	0.00	0.00
Adjusted Profit After Extra-ordinary item	10.05	1.22	-11.34	-35.38	-8.87	-3.75

EPS (Unit Curr.)	0.33	-0.34	-1.40	-3.77	-0.36	-0.15
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	49.89	49.89	49.89	49.89	49.89	49.89

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	8.97	7.18	-9.29	-17.24	3.52	1.12
PBDTM(%)	5.15	3.55	-12.44	-20.21	0.93	-1.29
PATM(%)	3.24	-1.99	-10.41	-25.21	-2.61	-1.32

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	49.89	49.67	49.67	49.67	49.37	48.75
Reserves Total	1008.48	982.28	979.84	836.54	868.42	899.87
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	9.14	0.00	0.00	0.00	0.00
Total Shareholders Funds	1058.37	1041.09	1029.51	886.21	917.79	948.62
Secured Loans	19.10	15.50	5.22	35.07	44.05	0.00
Unsecured Loans	1.18	1.35	0.44	0.00	0.00	0.00
Total Debt	20.28	16.85	5.66	35.07	44.05	0.00
Total Liabilities	1078.65	1057.94	1035.17	921.28	961.84	948.62
APPLICATION OF FUNDS :
Gross Block	110.04	112.17	102.86	99.30	73.33	37.61
Less : Accumulated Depreciation	53.32	45.26	37.08	29.89	20.90	13.93
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	56.72	66.91	65.78	69.41	52.43	23.68
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	2.20	1.40	4.34	3.72	0.03	3.12
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	632.52	658.61	685.18	757.71	788.26	686.66
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	47.95	67.99	45.79	31.42	25.33	13.83
Sundry Debtors	13.65	52.42	61.44	40.79	42.90	78.47
Cash and Bank	0.18	12.89	0.74	3.72	1.88	3.05
Loans and Advances	23.30	12.42	10.53	17.00	16.24	31.22
Total Current Assets	85.07	145.72	118.50	92.92	86.35	126.56
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	40.47	62.03	61.28	68.11	54.45	26.48
Provisions	1.13	2.30	3.38	4.94	1.02	0.21
Total Current Liabilities	41.60	64.33	64.65	73.05	55.48	26.69
Net Current Assets	43.47	81.40	53.84	19.87	30.87	99.88
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	12.37	8.31	8.79	9.48	9.16	8.93
Deferred Tax Liability	0.14	2.28	6.88	0.99	2.45	3.56
Net Deferred Tax	12.23	6.03	1.91	8.49	6.71	5.37
Total Assets	747.14	814.35	811.05	859.20	878.30	818.71
Contingent Liabilities	262.71	245.17	203.43	0.00	0.26	0.03

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	49.89	49.67	49.67	49.67	49.37	48.75
Reserves Total	648.89	633.29	677.98	637.43	657.32	598.83
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	9.14	0.00	0.00	0.00	0.00
Total Shareholders Funds	698.78	692.10	727.65	687.10	706.69	647.58
Minority Interest	50.41	48.01	48.67	44.74	40.25	36.99
Secured Loans	257.70	207.85	120.10	243.13	255.74	250.90
Unsecured Loans	185.89	157.05	156.89	100.28	69.33	53.68
Total Debt	443.59	364.90	276.99	343.41	325.07	304.58
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	21.84	18.67	10.19	77.73	48.48	112.91
Total Liabilities	1214.62	1123.68	1063.50	1152.98	1120.49	1102.06
APPLICATION OF FUNDS :
Gross Block	939.83	825.09	753.26	762.46	638.06	581.74
Less: Accumulated Depreciation	334.52	260.64	217.60	185.89	139.92	105.77
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	605.31	564.45	535.66	576.57	498.14	475.97
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	55.28	11.63	30.79	13.42	22.62	18.04
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.05	38.23	82.59	171.47	180.12	239.08
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	346.09	347.97	264.36	219.42	200.10	158.57
Sundry Debtors	340.96	329.24	346.14	318.76	278.25	258.35
Cash and Bank	41.75	59.25	56.20	75.83	72.04	42.45
Loans and Advances	61.04	45.28	41.24	49.95	49.12	61.30
Total Current Assets	789.84	781.74	707.93	663.96	599.51	520.67
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	279.48	295.99	292.57	279.13	247.29	218.39
Provisions	22.76	15.54	29.57	22.21	9.77	11.51
Total Current Liabilities	302.24	311.53	322.14	301.35	257.06	229.90
Net Current Assets	487.60	470.21	385.79	362.61	342.46	290.77
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	49.47	31.30	21.44	23.53	14.26	21.19
Deferred Tax Liability	16.36	17.87	7.86	8.61	10.33	10.81
Net Deferred Tax	33.11	13.43	13.58	14.92	3.93	10.38
Other Assets	33.28	25.73	15.08	13.99	73.23	67.81
Total Assets
Contingent Liabilities	0.96	1.67	2.27	0.00	0.26	0.03

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	12.80	0.44	2.87	1.07	1.00
Net Cash from Operating Activities	37.75	9.36	2.34	30.20	73.80
Net Cash Used In Investing Activities	-50.70	-4.25	16.55	-17.69	-114.06
Net Cash Used In Financing Activities	0.24	7.25	-21.33	-10.71	40.34
Net Inc./Dec In Cash And Cash Equivalents	-12.71	12.36	-2.44	1.81	0.07
Cash And Cash Equivalents At End Of The Year	0.08	12.80	0.44	2.87	1.07

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

52.79%

FII Shareholding

6.16%

DII Shareholding

7.59%

Public Shareholding

33.29%

**Promoter pledged shareholding 52.79%

About Sequent Scientific Ltd

Sequent Scientific Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 3081.75 crores. It has reported a sales of Rs. 42.21 crores and a net profit of Rs. 4.58 crores for the quarter ended December 2018. The company management includes Kamal K Sharma, Kausalya Santhanam,Sharat Narasapur,Krunal Shah,Neeraj Bharadwaj,Gregory John Andrews,Fabian Kausche,Kamal K Sharma,Milind Sarwate,N Rajaram,Hari Babu Bodepudi,PHILLIP TROTT (Sequent Scientific Ltd) among others.

Chairman

Kamal K Sharma

Registered office

301 Dosti Pinnacle 3rd Floor,Plot E7 Road No 22 Wagle Indl,Thane,Maharashtra,400604

FAX :91-022-41114754

Background

Incorporation Year1985

Face Value₹2

Market Lot1

How to buy Sequent Scien. shares on nse?

To buy Sequent Scien. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Sequent Scien. share price today?

The Sequent Scien. shares price on nse is Rs.123.65 today.

What is the market cap of Sequent Scien. shares on NSE ?

The company has a market capitalization of Rs.3084.25Cr

What is the PE & PB ratio of Sequent Scien. shares ?

PE is 0 and PB is 2.9

What is the 52 Week High and Low of Sequent Scien. shares?

Sequent Scien. stock price high: Rs.155.5 Sequent Scien. stock price low: Rs.70.6